GCAM Adds New Plasma Collection Centers

YONGIN, South Korea, Nov. 9, 2018 /CNW/ -- GCAM, Inc., a U.S. based plasma collection company, announced that it has added two additional plasma collection centers; one located in Indianapolis, Indiana, and another in Pasco, Washington. With the two newest additions, GCAM now runs 10 plasma donation centers nationwide.

"The centers are part of a GCAM mid-term plan to bring the number of plasma centers so that more patients ultimately may have access to a variety of live saving and life sustaining therapies from the collected plasma," said Jay Bae, GCAM President. "We are bringing job opportunities to these areas and also upping local economies through compensation to residents for their plasma donations."

Human plasma is the essential source for products to treating patients suffering from many different life-threatening disease and conditions, including immune deficiencies, hemophilia and other blood disorders.

GCAM, is a member of GC, the parent company of GC Pharma, one of the largest protein therapies makers in the world. GCAM collects high quality source plasma for GC Pharma and other plasma fractionators. A plasma center can collect up to 50,000 liters of source plasma annually.

About GCAM

GCAM, Inc., headquartered in Fullerton, CA, was established in 2009 and a member of South Korea's GC group of companies. GCAM runs source plasma centers in the United States. Its sister company, GC Pharma operates biopharmaceutical businesses on a global scale and GCBT, its immediate parent company owns state-of-art plasma fractionation facility in Montreal, Quebec.

This release includes forward-looking statements, which express the current beliefs and expectations of GCAM's management. Such statements speak only as of the date on which they are made and the Company undertakes no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.

SOURCE GC Pharma